Welcome to the first Red Leaf Securities Podcast of 2026, and we’re kicking off the year with a major name in the global medicinal cannabis industry.
Joining us today is Paul Long, CEO of Little Green Pharma (ASX:LGP) — a company that has firmly positioned itself as one of the leading pure-play medicinal cannabis producers globally.
Little Green Pharma has been at the forefront of industry consolidation, most notably with its proposed acquisition of Cannatrek, a transaction that would create one of the largest vertically integrated medicinal cannabis platforms across Australia and Europe. With Europe’s largest GMP-certified cultivation facility in Denmark, expanding international distribution, and a strengthened balance sheet post-merger, LGP is entering 2026 with significant momentum.
Today, we’ll speak with Paul about the strategic rationale behind the Cannatrek merger, how the combined group plans to leverage its European production capacity, navigate complex regulatory environments, and deploy its capital to drive growth, innovation, and further consolidation in what remains a rapidly evolving global market.
Paul, welcome to the Red Leaf Securities Podcast — great to have you with us.
Become a supporter of this podcast: https://www.spreaker.com/podcast/red-leaf-securities--6387900/support.
